Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022
Open Access
- 11 November 2022
- journal article
- research article
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 27 (45), 2200125
- https://doi.org/10.2807/1560-7917.es.2022.27.45.2200125
Abstract
Background The SARS-CoV-2 variant of concern Omicron was first detected in Italy in November 2021. Aim To comprehensively describe Omicron spread in Italy in the 2 subsequent months and its impact on the overall SARS-CoV-2 circulation at population level. Methods We analyse data from four genomic surveys conducted across the country between December 2021 and January 2022. Combining genomic sequencing results with epidemiological records collated by the National Integrated Surveillance System, the Omicron reproductive number and exponential growth rate are estimated, as well as SARS-CoV-2 transmissibility. Results Omicron became dominant in Italy less than 1 month after its first detection, representing on 3 January 76.9–80.2% of notified SARS-CoV-2 infections, with a doubling time of 2.7–3.3 days. As of 17 January 2022, Delta variant represented < 6% of cases. During the Omicron expansion in December 2021, the estimated mean net reproduction numbers respectively rose from 1.15 to a maximum of 1.83 for symptomatic cases and from 1.14 to 1.36 for hospitalised cases, while remaining relatively stable, between 0.93 and 1.21, for cases needing intensive care. Despite a reduction in relative proportion, Delta infections increased in absolute terms throughout December contributing to an increase in hospitalisations. A significant reproduction numbers’ decline was found after mid-January, with average estimates dropping below 1 between 10 and 16 January 2022. Conclusion Estimates suggest a marked growth advantage of Omicron compared with Delta variant, but lower disease severity at population level possibly due to residual immunity against severe outcomes acquired from vaccination and prior infection.Keywords
This publication has 16 references indexed in Scilit:
- Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational studyBMJ, 2022
- The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0–3.3 Days Can Be Explained by Immune EvasionViruses, 2022
- SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent PersonsThe New England Journal of Medicine, 2022
- Considerable escape of SARS-CoV-2 Omicron to antibody neutralizationNature, 2021
- The early phase of the COVID-19 epidemic in Lombardy, ItalyEpidemics, 2021
- Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in EnglandNature, 2021
- Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, ChinaNature Communications, 2021
- Rapid review of available evidence on the serial interval and generation time of COVID-19BMJ Open, 2020
- The challenges of the outbreak: the Italian COVID-19 integrated surveillance systemEuropean Journal of Public Health, 2020
- Authors’ response: Estimating the generation interval for COVID-19 based on symptom onset dataEurosurveillance, 2020